MetaCap

Cardiff Oncology Earnings

NASDAQ: CRDFHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.08+0.02 (+1.89%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Thu, Nov 5, 2026

Fiscal period

Sep/2026

EPS estimate

$-0.14

Cardiff Oncology earnings summary

Cardiff Oncology is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.14.

Summary generated from market data by MetaCap's automated system. Methodology

Related